Lumenis นำเสนอเครื่องเลเซอร์ MOSES Technology รุ่นล่าสุด

Reduction in Lithotripsy procedure time and benefits in BPH treatments

The world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announces the release of significant new clinical evidence in lithotripsy as well as initial clinical benefits in benign prostatic hyperplasia (BPH) treatments using the MOSES™ Technology at the 33rd annual European Association of Urology Congress (EAU18), taking place in Copenhagen, March 16-19, 2018.

MOSES is a revolutionary, patent-protected technology for holmium laser treatments in both urinary stones and BPH. The technology utilizes a proprietary combination of holmium lasers and fibers that optimize holmium energy transmission using a unique pulse modulation. Significant clinical evidence highlighting the benefits of MOSES in lithotripsy has already been released in several abstracts and peer-reviewed papers, namely MOSES’ reduced retropulsion and improved fragmentation rate.